AstraZeneca PLC is 155.7x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($286.27 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANIP | AZN |
|---|---|---|
| Market cap | $1.84 B | $286.27 B |
| US-listed rank | #2158 | #45 |
| Revenue (latest FY) | $883.37M | - |
| Net income (latest FY) | $78.00M | - |
| Net margin | 8.8% | - |
| P/E (trailing FY) | 23.6 | - |
| SEC filings | 1,742 | 1,004 |
AstraZeneca PLC is 155.7x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($286.27 B vs $1.84 B).
Full pages: ANI PHARMACEUTICALS INC and AstraZeneca PLC, or browse the full rankings.